Name: Ozempic vs. The Gym: Bank of America’s $250 Million GLP-1 Gamble For Employees
Uploaded: 2026-08-07T13:14:10-05:00
Description: Major American companies are spending hundreds of millions of dollars to cover GLP-1 weight loss drugs for their workforce. Bank of America alone is dedicating $250 million to provide these medications to qualifying employees. But is this the best way to handle corporate health?

Loading Video…

This browser does not support the Video element.

Ozempic vs. The Gym: Bank of America’s $250 Million GLP-1 Gamble For Employees

Major American companies are spending hundreds of millions of dollars to cover GLP-1 weight loss drugs for their workforce. Bank of America alone is dedicating $250 million to provide these medications to qualifying employees. But is this the best way to handle corporate health?

Posted August 7, 2026 1:14pm CDT